(Q36359670)

13 August 2017

1 reference

title

Intravenous immunoglobulin: adverse effects and safe administration (English)

1 reference

13 August 2017

4

Yehuda Shoenfeld

1 reference

13 August 2017

3

Yaniv Sherer

1 reference

13 August 2017

2

Uriel Katz

1 reference

13 August 2017

1

Hedi Orbach

1 reference

13 August 2017

publication date

1 December 2005

1 reference

Clinical Reviews in Allergy & Immunology

13 August 2017

published in

1 reference

13 August 2017

volume

29

1 reference

13 August 2017

issue

3

1 reference

13 August 2017

page(s)

173-184

1 reference

Therapy with Intravenous Immunoglobulins: Complications and Side-Effects

13 August 2017

cites work

1 reference

12 December 2020

Severe hemolytic anemia following high-dose intravenous immunoglobulin administration in a patient with Kawasaki disease

1 reference

12 December 2020

Drug-induced aseptic meningitis

1 reference

12 December 2020

Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency

1 reference

12 December 2020

Acute thromboembolic events associated with intravenous immunoglobulin infusion in antibody-deficient patients

1 reference

12 December 2020

A baboon syndrome induced by intravenous human immunoglobulins: report of a case and immunological analysis

1 reference

12 December 2020

Intravenous immunoglobulin therapy and renal dysfunction

1 reference

12 December 2020

The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile

1 reference

12 December 2020

Adverse effects of intravenous immunoglobulin therapy in 56 patients with autoimmune diseases

1 reference

12 December 2020

High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events

1 reference

12 December 2020

Myocardial infarction as a complication of immunoglobulin therapy

1 reference

12 December 2020

Macrophagelike vacuolated renal tubular cells in the urine of a male with osmotic nephrosis associated with intravenous immunoglobulin therapy. A case report

1 reference

12 December 2020

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

1 reference

12 December 2020

Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors

1 reference

12 December 2020

Deep venous thrombosis after high-dose intravenous immunoglobulin in the treatment of pemphigus vulgaris.

1 reference

12 December 2020

Intravenous immunoglobulin and the kidney--a two-edged sword

1 reference

12 December 2020

Severe cutaneous vasculitis following intravenous infusion of gammaglobulin in a patient with type II mixed cryoglobulinemia

1 reference

12 December 2020

Cerebral infarction complicating intravenous immunoglobulin therapy in a patient with Miller Fisher syndrome

1 reference

12 December 2020

Side effects of intravenous immunoglobulins in neurological autoimmune disorders--a prospective study

1 reference

12 December 2020

Thromboembolic complications of intravenous immunoglobulin treatment

1 reference

12 December 2020

Efficacy and safety of intravenous immunoglobulin for immune-mediated skin disease: current view

1 reference

12 December 2020

Clinical efficacy and safety of a novel intravenous immunoglobulin preparation in adult chronic ITP.

1 reference

12 December 2020

Acute renal failure and myocarditis associated with intravenous immunoglobulin therapy

1 reference

12 December 2020

Renal insufficiency and failure associated with immune globulin intravenous therapy--United States, 1985-1998.

1 reference

12 December 2020

Risks associated with the use of intravenous immunoglobulin

1 reference

12 December 2020

Acute myocardial infarction associated with high dose intravenous immunoglobulin infusion for autoimmune disorders. A study of four cases.

1 reference

12 December 2020

The clinical features of 16 cases of stroke associated with administration of IVIg

1 reference

12 December 2020

Deleterious effects of intravenous immunoglobulin in a patient with thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Intravenous immune globulins: an update for clinicians

1 reference

12 December 2020

Transverse sinus thrombosis and IVIg treatment: a case report and discussion of risk-benefit assessment for immunoglobulin treatment

1 reference

12 December 2020

NIH consensus conference. Intravenous immunoglobulin. Prevention and treatment of disease

1 reference

12 December 2020

Adverse reactions of intravenous immunoglobulin

1 reference

12 December 2020

Effect of high-dose intravenous immunoglobulin therapy on blood rheology

1 reference

12 December 2020

Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous immunoglobulin-related thrombotic complications

1 reference

12 December 2020

Arterial thrombosis induced by IVIg and its treatment with tPA

1 reference

12 December 2020

Drug-induced aseptic meningitis: diagnosis and management

1 reference

12 December 2020

Complications of intravenous immune globulin treatment in neurologic disease

1 reference

12 December 2020

Stroke and deep venous thrombosis complicating intravenous immunoglobulin infusions

1 reference

12 December 2020

Strokes, thromboembolic events, and IVIg: rare incidents blemish an excellent safety record

1 reference

12 December 2020

Immunoglobulin as a risk factor for contrast media nephrotoxicity

1 reference

12 December 2020

The safety of intravenous immunoglobulin preparations

1 reference

12 December 2020

Intravenous immunoglobulin therapy results in post‐infusional hyperproteinemia, increased serum viscosity, and pseudohyponatremia

1 reference

12 December 2020

In vivo administration of intravenous immunoglobulin (IVIg) can lead to enhanced erythrocyte sequestration.

1 reference

12 December 2020

Thrombosis complicating high dose intravenous immunoglobulin: report of three cases and review of the literature

1 reference

12 December 2020

Acute renal failure associated with intravenous immunoglobulins

1 reference

12 December 2020

Acute renal failure complicating high-dose intravenous immunoglobulin therapy for acquired haemophilia

1 reference

12 December 2020

Acute renal failure and intravenous immune globulin: occurs with sucrose-stabilized, but not with D-sorbitol-stabilized, formulation

1 reference

12 December 2020

Adverse effects of intravenous immunoglobulin therapy

1 reference

12 December 2020

i.v.IG for autoimmune, fibrosis, and malignant conditions: our experience with 200 patients

1 reference

12 December 2020

Thrombotic complications after intravenous immunoglobulin therapy in two patients

1 reference

12 December 2020

Iatrogenic central retinal vein occlusion and hyperviscosity associated with high-dose intravenous immunoglobulin administration

1 reference

12 December 2020

1 reference

12 December 2020

Neutropenia as a complication of high-dose intravenous immunoglobulin therapy in adult patients with neuroimmunologic disorders

1 reference

12 December 2020

Intravenous immune globulin and pseudohyponatremia

1 reference

12 December 2020

Complications of intravenous gammaglobulin in neuromuscular and other diseases

1 reference

12 December 2020

An infant with γ-globulin-induced hypersensitivity syndrome who developed Evans' syndrome after a second γ-globulin treatment

1 reference

12 December 2020

A new strategy for the prevention of IgA anaphylactic transfusion reactions

1 reference

12 December 2020

Identifiers

DOI

10.1385/CRIAI:29:3:173

1 reference

Dimensions Publication ID

13 August 2017

1015338304

0 references

1 reference